Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Opinion in Hematology
|
May 18, 2011
Non-MALT marginal zone lymphoma
Catherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
Haematologica
|
September 8, 2006
Telehematology: a pilot experience of cytological diagnosis of acute myeloid leukemia via the Internet. A GOELAMS study
Vincent Leymarie, Georges Flandrin, Maria Elena Noguera, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 11, 2003
Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma
Sophie Park, Maria-Elena Noguera, Josette Brière, et al.
European Journal of Haematology
|
May 6, 2015
Novel fusion between the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with chronic myeloid leukemia-like neoplasm: undetectable residual disease after imatinib therapy
Thomas Cluzeau, Eric Lippert, Jean-Michel Cayuela, et al.
Clinical Advances in Hematology & Oncology : H&O
|
March 7, 2008
ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia
Marjan Ertault-Daneshpouy, Maria Elena Noguera, Christian Gisselbrecht, et al.
Oncology (Williston Park, N.Y.)
|
April 12, 2012
Splenic marginal zone lymphoma: current knowledge and future directions
Catherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
The Journal of Clinical Investigation
|
December 25, 2010
Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients
Raphael Ceccaldi, Delphine Briot, Jérôme Larghero, et al.
Leukemia & Lymphoma
|
November 12, 2013
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment
Julien Lenglet, Catherine Traullé, Nicolas Mounier, et al.
Journal of Hematology & Oncology
|
January 29, 2016
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
Laura Guerenne, Stéphanie Beurlet, Mohamed Said, et al.
Oncotarget
|
September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
Carole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Opinion in Hematology
|
May 18, 2011
Non-MALT marginal zone lymphoma
Catherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
Haematologica
|
September 8, 2006
Telehematology: a pilot experience of cytological diagnosis of acute myeloid leukemia via the Internet. A GOELAMS study
Vincent Leymarie, Georges Flandrin, Maria Elena Noguera, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 11, 2003
Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma
Sophie Park, Maria-Elena Noguera, Josette Brière, et al.
European Journal of Haematology
|
May 6, 2015
Novel fusion between the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with chronic myeloid leukemia-like neoplasm: undetectable residual disease after imatinib therapy
Thomas Cluzeau, Eric Lippert, Jean-Michel Cayuela, et al.
Clinical Advances in Hematology & Oncology : H&O
|
March 7, 2008
ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia
Marjan Ertault-Daneshpouy, Maria Elena Noguera, Christian Gisselbrecht, et al.
Oncology (Williston Park, N.Y.)
|
April 12, 2012
Splenic marginal zone lymphoma: current knowledge and future directions
Catherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
The Journal of Clinical Investigation
|
December 25, 2010
Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients
Raphael Ceccaldi, Delphine Briot, Jérôme Larghero, et al.
Leukemia & Lymphoma
|
November 12, 2013
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment
Julien Lenglet, Catherine Traullé, Nicolas Mounier, et al.
Journal of Hematology & Oncology
|
January 29, 2016
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
Laura Guerenne, Stéphanie Beurlet, Mohamed Said, et al.
Oncotarget
|
September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
Carole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Page
of 2